Federated Hermes’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,326
| Closed | -$283K | – | 2266 |
|
|
2022
Q4 | $283K | Hold |
5,326
| – | – | ﹤0.01% | 1500 |
|
|
2022
Q3 | $299K | Buy |
5,326
+2,813
| +112% | +$186K | ﹤0.01% | 1455 |
|
|
2022
Q2 | $182K | Buy |
+2,513
| New | +$187K | ﹤0.01% | 1545 |
|
|
2021
Q4 | – | Sell |
-1,207
| Closed | -$111K | – | 2310 |
|
|
2021
Q3 | $111K | Buy |
1,207
+213
| +21% | +$20.5K | ﹤0.01% | 1761 |
|
|
2021
Q2 | $102K | Buy |
994
+401
| +68% | +$40.3K | ﹤0.01% | 1786 |
|
|
2021
Q1 | $58K | Buy |
593
+455
| +330% | +$41.4K | ﹤0.01% | 1855 |
|
|
2020
Q4 | $11K | Buy |
138
+4
| +3% | +$309 | ﹤0.01% | 1976 |
|
|
2020
Q3 | $10K | Sell |
134
-4
| -3% | -$321 | ﹤0.01% | 1965 |
|
|
2020
Q2 | $10K | Sell |
138
-12
| -8% | -$941 | ﹤0.01% | 1941 |
|
|
2020
Q1 | $10K | Sell |
150
-7,968
| -98% | -$554K | ﹤0.01% | 1875 |
|
|
2019
Q4 | $638K | Sell |
8,118
-43,508
| -84% | -$3.21M | ﹤0.01% | 1405 |
|
|
2019
Q3 | $3.53M | Sell |
51,626
-73,575
| -59% | -$4.94M | 0.01% | 859 |
|
|
2019
Q2 | $9.95M | Buy |
125,201
+10,918
| +10% | +$866K | 0.02% | 588 |
|
|
2019
Q1 | $9.59M | Buy |
114,283
+15,881
| +16% | +$1.66M | 0.02% | 582 |
|
|
2018
Q4 | $11.6M | Buy |
98,402
+16,625
| +20% | +$1.92M | 0.03% | 442 |
|
|
2018
Q3 | $9.86M | Buy |
81,777
+1,596
| +2% | +$198K | 0.02% | 572 |
|
|
2018
Q2 | $9.24M | Buy |
80,181
+49,095
| +158% | +$5.37M | 0.03% | 475 |
|
|
2018
Q1 | $2.67M | Sell |
31,086
-2,459
| -7% | -$190K | 0.01% | 845 |
|
|
2017
Q4 | $2.48M | Sell |
33,545
-200
| -0.6% | -$13.4K | 0.01% | 857 |
|
|
2017
Q3 | $1.95M | Buy |
33,745
+11,120
| +49% | +$657K | 0.01% | 928 |
|
|
2017
Q2 | $1.45M | Buy |
22,625
+13,435
| +146% | +$828K | ﹤0.01% | 1077 |
|
|
2017
Q1 | $529K | Sell |
9,190
-1,815
| -16% | -$108K | ﹤0.01% | 1320 |
|
|
2016
Q4 | $673K | Buy |
11,005
+29
| +0.3% | +$1.89K | ﹤0.01% | 1238 |
|
|
2016
Q3 | $760K | Buy |
10,976
+8,670
| +376% | +$572K | ﹤0.01% | 1176 |
|
|
2016
Q2 | $129K | Sell |
2,306
-9,650
| -81% | -$582K | ﹤0.01% | 1532 |
|
|
2016
Q1 | $725K | Sell |
11,956
-7,832
| -40% | -$461K | ﹤0.01% | 1180 |
|
|
2015
Q4 | $1.26M | Sell |
19,788
-756
| -4% | -$49K | ﹤0.01% | 1040 |
|
|
2015
Q3 | $1.38M | Buy |
20,544
+1,312
| +7% | +$92.8K | ﹤0.01% | 1003 |
|
|
2015
Q2 | $1.31M | Sell |
19,232
-11,390
| -37% | -$723K | ﹤0.01% | 1066 |
|
|
2015
Q1 | $1.7M | Buy |
30,622
+5,846
| +24% | +$300K | 0.01% | 1022 |
|
|
2014
Q4 | $1.27M | Buy |
24,776
+9,738
| +65% | +$478K | ﹤0.01% | 1104 |
|
|
2014
Q3 | $554K | Sell |
15,038
-15,372
| -51% | -$555K | ﹤0.01% | 1325 |
|
|
2014
Q2 | $1.19M | Sell |
30,410
-27,840
| -48% | -$1.03M | ﹤0.01% | 1139 |
|
|
2014
Q1 | $2.19M | Buy |
58,250
+2,336
| +4% | +$81.6K | 0.01% | 917 |
|
|
2013
Q4 | $2.11M | Sell |
55,914
-1,730
| -3% | -$66.2K | 0.01% | 907 |
|
|
2013
Q3 | $2.5M | Sell |
57,644
-13,202
| -19% | -$530K | 0.01% | 818 |
|
|
2013
Q2 | $2.56M | Buy |
+70,846
| New | +$2.15M | 0.01% | 801 |
|
Other funds holding USNA
Federated Hermes's USNA Position: Q1 2023 in Review
Federated Hermes sold out of Usana Health Sciences (USNA) in Q1 2023, closing a stake of 5,326 shares — an estimated $283K sold.
Federated Hermes first reported a position in USNA in Q2 2013 and held it in 37 quarters. The position peaked at $11.6M in Q4 2018. 176 funds tracked by Wall St. Rank hold USNA as of Q1 2023.
- Federated Hermes reported no remaining Usana Health Sciences position as of Q1 2023 after selling out during the quarter.
- Federated Hermes sold 5,326 Usana Health Sciences shares in Q1 2023, an estimated $283K.
- Federated Hermes first reported a position in Usana Health Sciences in Q2 2013 and held it in 37 quarters.
- Federated Hermes's Usana Health Sciences position peaked at $11.6M in Q4 2018.
- 176 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2023.
Based on Federated Hermes's 13F filing for Q1 2023, filed 8 May 2023.